Atlas Trials

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Clinical trial NCT07220083 · RECRUITING

Trial details

NCT number
NCT07220083
Sponsor
Boehringer Ingelheim
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Focal Segmental Glomerulosclerosis
Start date
2026-02-16
Primary completion
2028-12-27
Enrollment
286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.